CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis

Lu Han; De-Jun Cui; Bo Huang; Qian Yang; Tao Huang; Guo-Yuan Lin; Shao-Jie Chen

doi:doi:10.18632/aging.204776

← Back

Research Paper Volume 15, Issue 11 pp 5032—5051

CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis

Figure 1. CLDN5 alterations in pan-cancer. (A) The results from TCGA database indicated that CLDN5 expression is reduced in most tumors. (B) Co-occurrence of genetic mutations with CLDN5 alterations in tumors.